A point or points to consider.....
Is IMU looking to be takenover at this point in time.....I doubt it.
Why would big pharma look for a takeover of a company still formulating PH2 trials?
i:e....what are they buying, essentially at this stage the potential but more importantly
the risk.....
I would suggest a big pharma funded collaboration with IMU to continue their research
as per now..
Big pharma are increasingly shying away from expensive trials and prefer to leave
them to specialist research companies and then make a move....
IP protection is extremely important to IMU at this point in time, self protection is
the key to valuation....
Hard to believe?, page-101
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
-0.002(4.26%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 4.7¢ | 4.8¢ | 4.4¢ | $890.8K | 19.42M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 176601 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 969572 | 8 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
